You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫脈通(02192.HK)中期收益1.31億元 同比增長47.1%
格隆匯 08-26 21:43

格隆匯8月26日丨醫脈通(02192.HK)公吿,截至2021年6月30日止6個月的中期業績,收益1.31億元(人民幣,下同),同比增長47.1%;期內溢利1964.5萬元,同比下降43.1%;每股基本盈利3.67分。

集團是中國領先的在線專業醫師平台。二十多年來,集團致力以科技創新助力醫師作出更好的臨牀決策。集團自主開發的醫脈通平台亦廣獲中國醫師認可,已成為最受歡迎的專業醫療平台,讓集團成為中國製藥及醫療設備公司精準數字醫療營銷的首選平台。截至2021年6月30日,醫脈通平台可透過公司網站、桌面應用程序及移動應用程序登入,約有3.7百萬註冊用户,其中約2.5百萬用户為執業醫師,佔截至同日中國執業醫師總數約60%。

集團通過提供三類解決方案解決醫脈通平台參與者的不同需求從而獲得收益,即精準營銷及企業解決方案、醫學知識解決方案及智能患者管理解決方案。集團大部分收益來自精準營銷解決方案,該解決方案為製藥及醫療設備公司提供數字醫療營銷服務。集團亦提供多種企業解決方案,(i)讓製藥及醫療設備公司以具成效益的方式進行市場研究;及(ii)幫助製藥及醫療設備公司、醫院及醫療行業的其他參與者提升臨牀試驗及醫學研究的效率。

於2021年上半年,有65家醫療客户購買集團的精準營銷及企業解決方案,而2020年上半年有43家醫療客户。同期,有144種醫療產品使用集團的精準營銷及企業解決方案營銷,而2020年上半年有94種醫療產品使用該解決方案營銷。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account